This is an amended filing
[Amended] Material Event Report
AAI summary · Not investment advice
Adbiotech corrected its convertible bond issuance to KRW 11.3 billion with payment date moved to November 6, 2026.
Key facts
- Acquisition of other securities
- KRW 11.3 billion
- Coupon rate
- 6.0%
- Yield to maturity
- 6.0%
- Maturity date
- Nov 6, 2029Previously October 29, 2031
- Conversion period
- Nov 6, 2027 – Oct 6, 2029
- Payment date
- Nov 6, 2026Previously October 29, 2026
- Subscriber
- JK New Technology Investment Partnership No. 18Previously K Polaris Investment Partnership
Commentary
AI commentary · Not investment advice
What happened
Advbiotech amended its convertible bond issuance. The issue size was raised to KRW 11.3 billion, and the payment date was changed to November 6, 2026. The bonds are being issued to JK New Technology Investment Partnership No. 18. The full KRW 11.3 billion is earmarked for acquiring securities of another company.
In the company's terms
The bonds carry a coupon rate of 6.0% and a yield at maturity of 6.0%, with a maturity date of November 6, 2029. The materials state that the issue amounts to 19.0% of market capitalization.
What changes for shareholders
The number of shares to be issued upon conversion is 5,652,826. The conversion request period runs from November 6, 2027 to October 6, 2029. The amendment was filed on October 30, 2026.
Earlier Material Event Report filings from this company
- KRW 2.0 billion
- KRW 11.3 billion
- KRW 1.0 billion
■ This disclosure
| Filed | Title | Key figure · Note |
|---|---|---|
| 26.10.302026.10.30 | Material Event Report | KRW 1.0 billion · Series 12 unregistered unsecured private convertible bond |
| 26.10.302026.10.30 | [Amended] Material Event Report | KRW 2.0 billion · Series 10 unregistered unsecured private convertible bond |
Show Korean comments
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist